BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24474348)

  • 1. Cytotoxic effects of zoledronic acid on human epithelial cells and gingival fibroblasts.
    Basso FG; Pansani TN; de Oliveira CF; Turrioni AP; Soares DG; Hebling J; Costa CA
    Braz Dent J; 2013; 24(6):551-8. PubMed ID: 24474348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoledronic acid inhibits human osteoblast activities.
    Basso FG; Silveira Turrioni AP; Hebling J; de Souza Costa CA
    Gerontology; 2013; 59(6):534-41. PubMed ID: 23867757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of a co-culture model of epithelial cells and gingival fibroblasts to zoledronic acid.
    Basso FG; Soares DG; Pansani TN; Turrioni AP; Scheffel DL; Hebling J; Costa CA
    Braz Oral Res; 2016 Nov; 30(1):e122. PubMed ID: 27901204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of bisphosphonates on the adherence and metabolism of epithelial cells and gingival fibroblasts to titanium surfaces.
    Basso FG; Pansani TN; Soares DG; Cardoso LM; Hebling J; de Souza Costa CA
    Clin Oral Investig; 2018 Mar; 22(2):893-900. PubMed ID: 28688093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of zoledronic acid on odontoblast-like cells.
    Basso FG; Turrioni AP; Hebling J; de Souza Costa CA
    Arch Oral Biol; 2013 May; 58(5):467-73. PubMed ID: 23092609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of LPS treatment on the viability and chemokine synthesis by epithelial cells and gingival fibroblasts.
    Basso FG; Soares DG; Pansani TN; Turrioni AP; Scheffel DL; de Souza Costa CA; Hebling J
    Arch Oral Biol; 2015 Aug; 60(8):1117-21. PubMed ID: 26042620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide-mediated cytotoxic effect induced by zoledronic acid treatment on human gingival fibroblasts.
    De Colli M; Zara S; di Giacomo V; Patruno A; Marconi GD; Gallorini M; Zizzari VL; Tetè G; Cataldi A
    Clin Oral Investig; 2015 Jul; 19(6):1269-77. PubMed ID: 25352469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro synergistic effects of zoledronic acid and calcium on viability of human epithelial cells.
    Arai N; Inoue S; Tomihara K; Tsuno H; Noguchi M
    Oral Dis; 2013 Mar; 19(2):200-5. PubMed ID: 22891943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells.
    Açil Y; Möller B; Niehoff P; Rachko K; Gassling V; Wiltfang J; Simon MJ
    J Craniomaxillofac Surg; 2012 Dec; 40(8):e229-35. PubMed ID: 22082730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low-level laser therapy on the proliferation and apoptosis of gingival fibroblasts treated with zoledronic acid.
    Pansani TN; Basso FG; Turirioni AP; Kurachi C; Hebling J; de Souza Costa CA
    Int J Oral Maxillofac Surg; 2014 Aug; 43(8):1030-4. PubMed ID: 24656494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoledronic acid and geranylgeraniol regulate cellular behaviour and angiogenic gene expression in human gingival fibroblasts.
    Zafar S; Coates DE; Cullinan MP; Drummond BK; Milne T; Seymour GJ
    J Oral Pathol Med; 2014 Oct; 43(9):711-21. PubMed ID: 24762323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of alendronate and pamidronate on apoptosis and cell proliferation in cultured primary human gingival fibroblasts.
    Soydan SS; Araz K; Senel FV; Yurtcu E; Helvacioglu F; Dagdeviren A; Tekindal MA; Sahin F
    Hum Exp Toxicol; 2015 Nov; 34(11):1073-82. PubMed ID: 25636638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition.
    Patntirapong S; Singhatanadgit W; Chanruangvanit C; Lavanrattanakul K; Satravaha Y
    J Oral Pathol Med; 2012 Oct; 41(9):713-20. PubMed ID: 22563819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of different doses of zoledronic acid in establishing of bisphosphonate-related osteonecrosis.
    Silva PG; Ferreira Junior AE; Teófilo CR; Barbosa MC; Lima Júnior RC; Sousa FB; Mota MR; Ribeiro Rde A; Alves AP
    Arch Oral Biol; 2015 Sep; 60(9):1237-45. PubMed ID: 26093347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bisphosphonate zoledronic acid regulates key angiogenesis-related genes in primary human gingival fibroblasts.
    Ohlrich EJ; Coates DE; Cullinan MP; Milne TJ; Zafar S; Zhao Y; Duncan WD; Seymour GJ
    Arch Oral Biol; 2016 Mar; 63():7-14. PubMed ID: 26658366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis.
    Scheper MA; Badros A; Chaisuparat R; Cullen KJ; Meiller TF
    Br J Haematol; 2009 Mar; 144(5):667-76. PubMed ID: 19036117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro cytotoxicity of zoledronate (nitrogen-containing bisphosphonate: NBP) and/or etidronate (non-NBP) in tumour cells and periodontal cells.
    Tanaka Y; Nagai Y; Dohdoh M; Oizumi T; Ohki A; Kuroishi T; Sugawara S; Endo Y
    Arch Oral Biol; 2013 Jun; 58(6):628-37. PubMed ID: 23245859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells.
    Anitua E; Zalduendo M; Troya M; Orive G
    Clin Oral Investig; 2016 Apr; 20(3):513-21. PubMed ID: 26201455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro comparison of new bisphosphonic acids and zoledronate effects on human gingival fibroblasts viability, inflammation and matrix turnover.
    De Colli M; Tortorella P; Marconi GD; Agamennone M; Campestre C; Tauro M; Cataldi A; Zara S
    Clin Oral Investig; 2016 Nov; 20(8):2013-2021. PubMed ID: 26689567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of ozone application on genotoxic damage and wound healing in bisphosphonate-applied human gingival fibroblast cells.
    Akdeniz SS; Beyler E; Korkmaz Y; Yurtcu E; Ates U; Araz K; Sahin FI; Torun OY
    Clin Oral Investig; 2018 Mar; 22(2):867-873. PubMed ID: 28699091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.